SAN

83.43

0%↓

MRK1

117.75

-1.01%↓

SHL.DE

+0.89%↑

ARGX

752.2

-0.61%↓

FRE

47.76

-0.27%↓

SAN

83.43

0%↓

MRK1

117.75

-1.01%↓

SHL.DE

+0.89%↑

ARGX

752.2

-0.61%↓

FRE

47.76

-0.27%↓

SAN

83.43

0%↓

MRK1

117.75

-1.01%↓

SHL.DE

+0.89%↑

ARGX

752.2

-0.61%↓

FRE

47.76

-0.27%↓

SAN

83.43

0%↓

MRK1

117.75

-1.01%↓

SHL.DE

+0.89%↑

ARGX

752.2

-0.61%↓

FRE

47.76

-0.27%↓

SAN

83.43

0%↓

MRK1

117.75

-1.01%↓

SHL.DE

+0.89%↑

ARGX

752.2

-0.61%↓

FRE

47.76

-0.27%↓

Strona główna・Stock List・Vetoquinol SA

Vetoquinol SA

Closed

SectorHealthcare

77 0.26

Buy Sell

Overview

Share price change

24h

Current

Min

74.6

Max

77.1

Key metrics
By Trading Economics
Income	-9.8M 25M
Sales	-17M 258M
P/E Sector Avg	15.137 77.671
Dividend yield	1.19
Profit margin	9.734
Employees	2,497
EBITDA	-12M 48M

Dividends
By Dow Jones
Dividend yield Sector Avg	1.19% 2.35%

Market Stats
By TradingEconomics
Market Cap	3.7M 913M
Previous open	76.74
Previous close	77

News Sentiment

By Acuity

50%

187 / 374 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

72.6 / 75.1 Support & Resistance

Vetoquinol SA Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

11 gru 2025, 23:58 UTC

Acquisitions, Mergers, Takeovers

Destination XL to Merge With Oaktree-Backed Fullbeauty Brands -- Update

11 gru 2025, 23:56 UTC

Earnings

Costco Logs Higher Sales, Eyes Expansion to Fuel Membership Growth -- Update

11 gru 2025, 23:03 UTC

Acquisitions, Mergers, Takeovers

FTC Sues to Block Henkel's $725 Million Acquisition of Liquid Nails From PE Firm

11 gru 2025, 22:06 UTC

Acquisitions, Mergers, Takeovers

Scentre to Sell $456 Million Westfield Chermside Mall Stake to Dexus-Managed Fund

11 gru 2025, 21:50 UTC

Earnings

Costco Same-Store Sales, Membership Fees Rose in 1Q

11 gru 2025, 23:45 UTC

Market Talk

Global Equities Roundup: Market Talk

11 gru 2025, 23:44 UTC

Market Talk

Nikkei May Rise After U.S. Stock Indexes Hit Record Highs -- Market Talk

11 gru 2025, 23:37 UTC

Market Talk

Gold Steady, Underpinned by Dollar's Weakness -- Market Talk

11 gru 2025, 23:31 UTC

Earnings

Broadcom Beats Revenue and Profit Forecasts as AI Chip Sales Climb -- Update

11 gru 2025, 22:48 UTC

Acquisitions, Mergers, Takeovers

FTC Sues to Block Henkel's $725M Acquisition of Liquid Nails From PE Firm

11 gru 2025, 22:35 UTC

Earnings

Costco Sold 4.5 Million Pies Ahead of Thanksgiving. Despite Earnings Beat, the Stock Fails to Gain Traction. -- Barrons.com

11 gru 2025, 22:30 UTC

Earnings

Broadcom Beats Earnings. The Stock Wavers After Customer Updates. -- Barrons.com

11 gru 2025, 22:09 UTC

Acquisitions, Mergers, Takeovers

FTC Alleges Henkel Deal Would Combine Two Biggest Brands of Construction Adhesives Sold at Stores Like Home Depot, Leading to Higher Prices

11 gru 2025, 22:06 UTC

Acquisitions, Mergers, Takeovers

FTC Sues to Block Henkel From Buying Loctite Competitor Liquid Nails

11 gru 2025, 22:05 UTC

Earnings

Broadcom Beats Revenue and Profit Forecasts as AI Chip Sales Climb -- Update

11 gru 2025, 21:51 UTC

Acquisitions, Mergers, Takeovers

Scentre to Sell $456M Westfield Chermside Mall Stake to Dexus-Managed Fund

11 gru 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

11 gru 2025, 21:39 UTC

Earnings

Broadcom Beats Earnings. The Stock Rises. -- Barrons.com

11 gru 2025, 21:39 UTC

Earnings

Broadcom Reports $18 Billion in Revenue as AI Chip Sales Climb -- WSJ

11 gru 2025, 21:38 UTC

Earnings

Costco Tops Earnings Estimates but Stock Fails to Gain Traction -- Barrons.com

11 gru 2025, 21:37 UTC

Earnings

These Stocks Moved the Most Today: Oracle, Nvidia, Broadcom, Planet Labs, Visa, Ciena, Gemini Space Station, and More -- Barrons.com

11 gru 2025, 21:37 UTC

Market Talk

Broadcom Sees AI Revenue Doubling -- Market Talk

11 gru 2025, 21:34 UTC

Acquisitions, Mergers, Takeovers

Scentre Will Temporarily Invest A$50M in the New Dexus Fund

11 gru 2025, 21:29 UTC

Acquisitions, Mergers, Takeovers

Dexus Aiming for Long-Term Holding of A$50M in Fund

11 gru 2025, 21:28 UTC

Market Talk

BLS Publishing Calendar Delays Now Pushing Economic Data Into February -- Market Talk

11 gru 2025, 21:28 UTC

Acquisitions, Mergers, Takeovers

Dexus Expects to Introduce Additional Third-Party Equity in FY26

11 gru 2025, 21:28 UTC

Acquisitions, Mergers, Takeovers

Dexus: Third Party Investors to Contribute Remainder

11 gru 2025, 21:27 UTC

Acquisitions, Mergers, Takeovers

Dexus to Put Initial A$170M into New Dexus Strategic Investment Trust

11 gru 2025, 21:26 UTC

Acquisitions, Mergers, Takeovers

Scentre: Dexus Wholesale Shopping Centre Fund Already Holds 25% Stake

11 gru 2025, 21:25 UTC

Acquisitions, Mergers, Takeovers

Scentre: Purchase Price Represents Book Value, 5% Value Cap Rate

Peer Comparison

Price change

Vetoquinol SA Forecast

Rating Consensus

By TipRanks

0 ratings

Buy

Hold

Sell

Based on 0 analysts giving stock ratings to Vetoquinol SA - Dist in the past 3 months.

Technical Score

By Trading Central

72.6 / 75.1Support & Resistance

Recent bearish events outweigh bullish events.

All events are bearish.

Sentiment

By Acuity

187 / 374 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Vetoquinol SA

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.